Insulin Price Increases Driven by Collusion Between Major Drug Cos, Claims Class Action Lawsuit

A group of clinics that serve low-income patients has launched an antitrust class action lawsuit against four major pharmaceutical companies. Why: The clinics say that Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca conspired to cause insulin price increases by unilaterally refusing to offer the medications at a discount allegedly mandated by federal public health law.

Read the source article at Top Class Actions
2021-08-09 16:59:48